Darunavir is better tolerated than the older protease inhibitors and less well tolerated than integrase inhibitors. Its effects are mostly gastrointestinal early on, with one specific risk worth knowing about.
What happens in the first weeks?
Diarrhoea is the most common, along with nausea, abdominal discomfort and headache. These generally settle within two to four weeks. Taking it with a substantial meal helps, and it should be taken with food anyway.
What can you do about diarrhoea?
Give it a few weeks, since it frequently improves. Simple measures such as avoiding very fatty meals help some people. If it persists beyond a month, say so rather than enduring it, because it is a common reason people quietly stop.
What is the rash risk?
Darunavir contains a sulfonamide component, and rash occurs in a minority of people, usually within the first few weeks. Most rashes are mild, do not spread and settle without stopping the drug.
When is a rash serious?
Any rash accompanied by fever, blistering, peeling skin, or involvement of the mouth, eyes or genitals is an emergency and needs immediate attention. Severe reactions including Stevens-Johnson syndrome have been reported rarely. Do not wait to see how it develops.
What about a sulfonamide allergy?
Worth mentioning before starting. A history of severe reaction to sulfonamide antibiotics is a reason for caution, though cross-reactivity is not straightforward and this is a clinical judgement rather than an automatic exclusion.
What about lipids?
Cholesterol and triglycerides tend to rise on boosted protease inhibitors, contributing to cardiovascular risk over time. Darunavir is better than older drugs in the class and worse than integrase inhibitors. Lipids are monitored routinely and treated where needed.
What about the liver?
Liver enzyme rises occur and are monitored, more commonly in people with hepatitis B or C. Yellowing of the eyes or skin, dark urine, persistent nausea or pain under the right ribs warrant prompt contact rather than waiting.
What about blood sugar?
Protease inhibitors as a class have been associated with insulin resistance and new-onset diabetes, more so with older drugs than with darunavir. Blood glucose is monitored as part of routine bloods.
What effects come from the booster?
A good proportion. Nausea and diarrhoea are more common with ritonavir than cobicistat, and the creatinine rise seen on cobicistat is a laboratory change rather than kidney damage. Distinguishing booster from drug is frequently not possible without changing one.
What about long-term use?
Generally well tolerated over years. The main considerations are cardiovascular risk from the lipid effects and the cumulative interaction burden of the booster rather than any direct organ toxicity.
What monitoring is there?
Blood tests every three to six months covering viral load, liver and kidney function, lipids and glucose. Most changes appear on a test before anyone notices a symptom.
Should you look side effects up online?
The patient information leaflet lists everything ever reported, which is alarming and unhelpful for judging likelihood. A clinic pharmacist will tell you which effects are common and which matter, in about two minutes.
How long should you give it?
Four weeks is a reasonable trial for early effects, most of which settle in that window. Beyond a month, effects attributed to darunavir are less likely to resolve on their own and more likely to warrant a change.
What is worth recording?
When something started, how long it lasts and whether anything changed at the same time. A short note is considerably more useful at an appointment than trying to reconstruct whether a symptom followed starting darunavir or something else.
Who should you tell?
Your HIV clinic first, since they know the regimen. A GP can help with symptoms and will not usually change antiretrovirals. A clinic pharmacist is often the quickest route to an answer about whether darunavir is the likely cause.
Are side effects a reason to stop?
Not to stop, and frequently a reason to change. Stopping leaves you untreated; switching keeps you covered. Almost every side effect discussed here has an alternative regimen that avoids it, so the conversation is worth having.